Related trials
BASKET-PROVE (SES), 2010 - sirolimus eluting stent vs bare-metal stent
SPIRIT IV, 2010 - everolimus eluting stent vs paclitaxel eluting stent
ISAR-DESIRE-2, 2010 - sirolimus eluting stent vs paclitaxel eluting stent
SORT-OUT-3, 2010 - zotarolimus eluting stent vs sirolimus eluting stent
GISSOC II, 2010 - sirolimus eluting stent vs bare-metal stent
RESOLUTE, 2010 - zotarolimus eluting stent vs everolimus eluting stent
BASKET-PROVE (EES), 2010 - everolimus eluting stent vs bare-metal stent
ISAR TEST 3 (BP), 2009 - sirolimus biodegradable polymer vs sirolimus eluting stent
SYNTAX, 2009 - paclitaxel eluting stent vs CABG
ISAR-LEFT-MAIN, 2009 - sirolimus eluting stent vs paclitaxel eluting stent
STICH (ventricular reconstruction), 2009 - CABG+surgical ventricular reconstruction vs CABG
NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis
ZEST AMI (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
Juwana, 2009 - sirolimus eluting stent vs paclitaxel eluting stent
DEBATER (SES vs BMS), 2009 - sirolimus eluting stent vs bare-metal stent
ISAR TEST 2 (vs ZES), 2009 - dual sirolimus, probucol eluting stent vs zotarolimus eluting stent
ZEST (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
ENDEAVOR IV, 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
BARI 2D, 2009 - CABG or PCI vs medical treatment
ZEST (vs SES), 2009 - zotarolimus eluting stent vs sirolimus eluting stent
ISAR-TEST-4 (biodegradable polymer), 2009 - sirolimus biodegradable polymer vs sirolimus eluting stent
PASEO, 2009 - drug-eluting stents vs bare-metal stent
COMPARE, 2009 - everolimus eluting stent vs paclitaxel eluting stent
ISAR TEST 2 (vs SES), 2009 - dual sirolimus, probucol eluting stent vs sirolimus eluting stent
ISAR TEST 3 (PF), 2009 - polymer free sirolimus stent vs sirolimus eluting stent
See also:
All acute myocardial infarction clinical trials
All coronary artery disease clinical trials
All clinical trials of PCI
All clinical trials of paclitaxel eluting stent
|
|
Treatments
Studied treatment |
Taxus Express
|
Control treatment |
Bare-metal-stent
|
Concomittant treatment |
After PCI, patients were treated with a 300- to 600-mg loading dose of clopidogrel, followed by clopidogrel 75 mg daily for one year |
Patients
Patients |
AMI - STEMI patients undergoing PCI |
Baseline characteristics |
age |
63 |
diabetes (%) |
15% |
Lesion diameter inclusion criteria |
NA |
Female (%) |
28% |
|
Method and design
Randomized effectives |
70 / 75 (studied vs. control) |
Design |
Parallel groups |
Blinding |
open |
Follow-up duration |
12 months |
Number of centre |
1 |
Geographic area |
Finland |
Primary endpoint |
none |
Results
Endpoint
Studied treat. n/N
Control treat. n/N
Graph
RR [95% CI]
All cause death
8 / 70
4 / 75
classic
2,14 [0,67;6,80]
angiographic restenosis
NA / 70
NA / 75
Stent thrombosis (any, end of follow up)
1 / 70
3 / 75
classic
0,36 [0,04;3,35]
0
2
1.0
Relative risks
|
Endpoint |
Events (%) |
Relative Risk |
95% CI |
Endpoint definition in the trial |
Ref |
Studied treat. |
Control treat. |
All cause death
|
8 / 70 (11,4%) |
4 / 75 (5,3%) |
2,14 |
[0,67;6,80] |
|
|
Stent thrombosis (any, end of follow up)
|
1 / 70 (1,4%) |
3 / 75 (4,0%) |
0,36 |
[0,04;3,35] |
|
|
The primary endpoint (if exists) appears in blod characters
|
Reference(s) used for data extraction:
0:
|
Endpoint |
studied treat. |
control treat. |
mean diff |
Absolute risk reduction
|
Endpoint |
Events rate |
Absolute risk reduction (ARR) |
Studied treat. |
Control treat. |
All cause death |
11,43% |
5,33% |
6,1%
|
Stent thrombosis (any, end of follow up) |
1,43% |
4,00% |
-25,7‰
|
Meta-analysis of all similar trials:
Drug eluting stent in coronary artery disease for all type of patients
Drug eluting stent in coronary artery disease for acute myocardial infarction
myocardial revascularization in acute myocardial infarction for all type of patients
myocardial revascularization in coronary artery disease for all type of patient
PCI in acute myocardial infarction for all type of patients
Reference(s)
unpublished (or not yet fully published) trial
-
Tierala I, Syvaenne M, Kupari M.
Randomised comparison of apaclitaxel-eluting and a bare metal stent in STEMI-PCI. TheHAAMU-STENT-study.
Annual Scientifi c Meeting of theTranscatheter Cardiovascular Therapeutics; Washington, DC;Oct 2227, 2006. Abstract 178.
Pubmed
|
Hubmed
| Fulltext
|